Global Arthritic Therapeutic Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Arthritic Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Arthritic Therapeutic market size is estimated to be worth US$ 28030 million in 2021 and is forecast to a readjusted size of USD 35720 million by 2028 with a CAGR of 3.5% during review period. Rheumatoid Arthritis accounting for % of the Arthritic Therapeutic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biologics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Arthritic Therapeutic include AbbVie, Merck., Novartis, AstraZeneca, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Arthritic Therapeutic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biologics
Non-biologics
Market segment by Application, can be divided into
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
Market segment by players, this report covers
AbbVie
Merck.
Novartis
AstraZeneca
Abbott
Amgen
Baxter
Bristol-Myers Squibb
F. Hoffmann-La Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Celgene
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Arthritic Therapeutic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Arthritic Therapeutic, with revenue, gross margin and global market share of Arthritic Therapeutic from 2019 to 2022.
Chapter 3, the Arthritic Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Arthritic Therapeutic market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Arthritic Therapeutic research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Arthritic Therapeutic
1.2 Classification of Arthritic Therapeutic by Type
1.2.1 Overview: Global Arthritic Therapeutic Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Arthritic Therapeutic Revenue Market Share by Type in 2021
1.2.3 Biologics
1.2.4 Non-biologics
1.3 Global Arthritic Therapeutic Market by Application
1.3.1 Overview: Global Arthritic Therapeutic Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Others
1.4 Global Arthritic Therapeutic Market Size & Forecast
1.5 Global Arthritic Therapeutic Market Size and Forecast by Region
1.5.1 Global Arthritic Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Arthritic Therapeutic Market Size by Region, (2017-2022)
1.5.3 North America Arthritic Therapeutic Market Size and Prospect (2017-2028)
1.5.4 Europe Arthritic Therapeutic Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Arthritic Therapeutic Market Size and Prospect (2017-2028)
1.5.6 South America Arthritic Therapeutic Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Arthritic Therapeutic Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Arthritic Therapeutic Market Drivers
1.6.2 Arthritic Therapeutic Market Restraints
1.6.3 Arthritic Therapeutic Trends Analysis
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Arthritic Therapeutic Product and Solutions
2.1.4 AbbVie Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Merck.
2.2.1 Merck. Details
2.2.2 Merck. Major Business
2.2.3 Merck. Arthritic Therapeutic Product and Solutions
2.2.4 Merck. Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck. Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Arthritic Therapeutic Product and Solutions
2.3.4 Novartis Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Novartis Recent Developments and Future Plans
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Arthritic Therapeutic Product and Solutions
2.4.4 AstraZeneca Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 AstraZeneca Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Arthritic Therapeutic Product and Solutions
2.5.4 Abbott Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Arthritic Therapeutic Product and Solutions
2.6.4 Amgen Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business
2.7.3 Baxter Arthritic Therapeutic Product and Solutions
2.7.4 Baxter Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Baxter Recent Developments and Future Plans
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Arthritic Therapeutic Product and Solutions
2.8.4 Bristol-Myers Squibb Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Arthritic Therapeutic Product and Solutions
2.9.4 F. Hoffmann-La Roche Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Arthritic Therapeutic Product and Solutions
2.10.4 Eli Lilly Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Eli Lilly Recent Developments and Future Plans
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Arthritic Therapeutic Product and Solutions
2.11.4 Johnson & Johnson Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Johnson & Johnson Recent Developments and Future Plans
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Arthritic Therapeutic Product and Solutions
2.12.4 GlaxoSmithKline Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 GlaxoSmithKline Recent Developments and Future Plans
2.13 Celgene
2.13.1 Celgene Details
2.13.2 Celgene Major Business
2.13.3 Celgene Arthritic Therapeutic Product and Solutions
2.13.4 Celgene Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Celgene Recent Developments and Future Plans
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Arthritic Therapeutic Product and Solutions
2.14.4 Pfizer Arthritic Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Arthritic Therapeutic Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Arthritic Therapeutic Players Market Share in 2021
3.2.2 Top 10 Arthritic Therapeutic Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Arthritic Therapeutic Players Head Office, Products and Services Provided
3.4 Arthritic Therapeutic Mergers & Acquisitions
3.5 Arthritic Therapeutic New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Arthritic Therapeutic Revenue and Market Share by Type (2017-2022)
4.2 Global Arthritic Therapeutic Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Arthritic Therapeutic Revenue Market Share by Application (2017-2022)
5.2 Global Arthritic Therapeutic Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Arthritic Therapeutic Revenue by Type (2017-2028)
6.2 North America Arthritic Therapeutic Revenue by Application (2017-2028)
6.3 North America Arthritic Therapeutic Market Size by Country
6.3.1 North America Arthritic Therapeutic Revenue by Country (2017-2028)
6.3.2 United States Arthritic Therapeutic Market Size and Forecast (2017-2028)
6.3.3 Canada Arthritic Therapeutic Market Size and Forecast (2017-2028)
6.3.4 Mexico Arthritic Therapeutic Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Arthritic Therapeutic Revenue by Type (2017-2028)
7.2 Europe Arthritic Therapeutic Revenue by Application (2017-2028)
7.3 Europe Arthritic Therapeutic Market Size by Country
7.3.1 Europe Arthritic Therapeutic Revenue by Country (2017-2028)
7.3.2 Germany Arthritic Therapeutic Market Size and Forecast (2017-2028)
7.3.3 France Arthritic Therapeutic Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Arthritic Therapeutic Market Size and Forecast (2017-2028)
7.3.5 Russia Arthritic Therapeutic Market Size and Forecast (2017-2028)
7.3.6 Italy Arthritic Therapeutic Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Arthritic Therapeutic Revenue by Type (2017-2028)
8.2 Asia-Pacific Arthritic Therapeutic Revenue by Application (2017-2028)
8.3 Asia-Pacific Arthritic Therapeutic Market Size by Region
8.3.1 Asia-Pacific Arthritic Therapeutic Revenue by Region (2017-2028)
8.3.2 China Arthritic Therapeutic Market Size and Forecast (2017-2028)
8.3.3 Japan Arthritic Therapeutic Market Size and Forecast (2017-2028)
8.3.4 South Korea Arthritic Therapeutic Market Size and Forecast (2017-2028)
8.3.5 India Arthritic Therapeutic Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Arthritic Therapeutic Market Size and Forecast (2017-2028)
8.3.7 Australia Arthritic Therapeutic Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Arthritic Therapeutic Revenue by Type (2017-2028)
9.2 South America Arthritic Therapeutic Revenue by Application (2017-2028)
9.3 South America Arthritic Therapeutic Market Size by Country
9.3.1 South America Arthritic Therapeutic Revenue by Country (2017-2028)
9.3.2 Brazil Arthritic Therapeutic Market Size and Forecast (2017-2028)
9.3.3 Argentina Arthritic Therapeutic Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Arthritic Therapeutic Revenue by Type (2017-2028)
10.2 Middle East & Africa Arthritic Therapeutic Revenue by Application (2017-2028)
10.3 Middle East & Africa Arthritic Therapeutic Market Size by Country
10.3.1 Middle East & Africa Arthritic Therapeutic Revenue by Country (2017-2028)
10.3.2 Turkey Arthritic Therapeutic Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Arthritic Therapeutic Market Size and Forecast (2017-2028)
10.3.4 UAE Arthritic Therapeutic Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Arthritic Therapeutic Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Arthritic Therapeutic Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Arthritic Therapeutic Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Arthritic Therapeutic Revenue (USD Million) by Region (2017-2022)
Table 5. Global Arthritic Therapeutic Revenue Market Share by Region (2023-2028)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Arthritic Therapeutic Product and Solutions
Table 9. AbbVie Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck. Corporate Information, Head Office, and Major Competitors
Table 11. Merck. Major Business
Table 12. Merck. Arthritic Therapeutic Product and Solutions
Table 13. Merck. Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Arthritic Therapeutic Product and Solutions
Table 17. Novartis Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Arthritic Therapeutic Product and Solutions
Table 21. AstraZeneca Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Arthritic Therapeutic Product and Solutions
Table 25. Abbott Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Arthritic Therapeutic Product and Solutions
Table 29. Amgen Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Baxter Corporate Information, Head Office, and Major Competitors
Table 31. Baxter Major Business
Table 32. Baxter Arthritic Therapeutic Product and Solutions
Table 33. Baxter Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 35. Bristol-Myers Squibb Major Business
Table 36. Bristol-Myers Squibb Arthritic Therapeutic Product and Solutions
Table 37. Bristol-Myers Squibb Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 39. F. Hoffmann-La Roche Major Business
Table 40. F. Hoffmann-La Roche Arthritic Therapeutic Product and Solutions
Table 41. F. Hoffmann-La Roche Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 43. Eli Lilly Major Business
Table 44. Eli Lilly Arthritic Therapeutic Product and Solutions
Table 45. Eli Lilly Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 47. Johnson & Johnson Major Business
Table 48. Johnson & Johnson Arthritic Therapeutic Product and Solutions
Table 49. Johnson & Johnson Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 51. GlaxoSmithKline Major Business
Table 52. GlaxoSmithKline Arthritic Therapeutic Product and Solutions
Table 53. GlaxoSmithKline Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Celgene Corporate Information, Head Office, and Major Competitors
Table 55. Celgene Major Business
Table 56. Celgene Arthritic Therapeutic Product and Solutions
Table 57. Celgene Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Pfizer Corporate Information, Head Office, and Major Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Arthritic Therapeutic Product and Solutions
Table 61. Pfizer Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Arthritic Therapeutic Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Arthritic Therapeutic Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Arthritic Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Arthritic Therapeutic Players Head Office, Products and Services Provided
Table 66. Arthritic Therapeutic Mergers & Acquisitions in the Past Five Years
Table 67. Arthritic Therapeutic New Entrants and Expansion Plans
Table 68. Global Arthritic Therapeutic Revenue (USD Million) by Type (2017-2022)
Table 69. Global Arthritic Therapeutic Revenue Share by Type (2017-2022)
Table 70. Global Arthritic Therapeutic Revenue Forecast by Type (2023-2028)
Table 71. Global Arthritic Therapeutic Revenue by Application (2017-2022)
Table 72. Global Arthritic Therapeutic Revenue Forecast by Application (2023-2028)
Table 73. North America Arthritic Therapeutic Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Arthritic Therapeutic Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Arthritic Therapeutic Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Arthritic Therapeutic Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Arthritic Therapeutic Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Arthritic Therapeutic Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Arthritic Therapeutic Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Arthritic Therapeutic Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Arthritic Therapeutic Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Arthritic Therapeutic Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Arthritic Therapeutic Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Arthritic Therapeutic Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Arthritic Therapeutic Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Arthritic Therapeutic Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Arthritic Therapeutic Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Arthritic Therapeutic Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Arthritic Therapeutic Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Arthritic Therapeutic Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Arthritic Therapeutic Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Arthritic Therapeutic Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Arthritic Therapeutic Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Arthritic Therapeutic Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Arthritic Therapeutic Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Arthritic Therapeutic Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Arthritic Therapeutic Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Arthritic Therapeutic Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Arthritic Therapeutic Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Arthritic Therapeutic Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Arthritic Therapeutic Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Arthritic Therapeutic Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Arthritic Therapeutic Picture
Figure 2. Global Arthritic Therapeutic Revenue Market Share by Type in 2021
Figure 3. Biologics
Figure 4. Non-biologics
Figure 5. Arthritic Therapeutic Revenue Market Share by Application in 2021
Figure 6. Rheumatoid Arthritis Picture
Figure 7. Osteoarthritis Picture
Figure 8. Psoriatic Arthritis Picture
Figure 9. Ankylosing Spondylitis Picture
Figure 10. Fibromyalgia Picture
Figure 11. Others Picture
Figure 12. Global Arthritic Therapeutic Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Arthritic Therapeutic Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Arthritic Therapeutic Revenue Market Share by Region (2017-2028)
Figure 15. Global Arthritic Therapeutic Revenue Market Share by Region in 2021
Figure 16. North America Arthritic Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Arthritic Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Arthritic Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Arthritic Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Arthritic Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Arthritic Therapeutic Market Drivers
Figure 22. Arthritic Therapeutic Market Restraints
Figure 23. Arthritic Therapeutic Market Trends
Figure 24. AbbVie Recent Developments and Future Plans
Figure 25. Merck. Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. AstraZeneca Recent Developments and Future Plans
Figure 28. Abbott Recent Developments and Future Plans
Figure 29. Amgen Recent Developments and Future Plans
Figure 30. Baxter Recent Developments and Future Plans
Figure 31. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 32. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 33. Eli Lilly Recent Developments and Future Plans
Figure 34. Johnson & Johnson Recent Developments and Future Plans
Figure 35. GlaxoSmithKline Recent Developments and Future Plans
Figure 36. Celgene Recent Developments and Future Plans
Figure 37. Pfizer Recent Developments and Future Plans
Figure 38. Global Arthritic Therapeutic Revenue Share by Players in 2021
Figure 39. Arthritic Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Arthritic Therapeutic Revenue Market Share in 2021
Figure 41. Global Top 10 Players Arthritic Therapeutic Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Arthritic Therapeutic Revenue Share by Type in 2021
Figure 44. Global Arthritic Therapeutic Market Share Forecast by Type (2023-2028)
Figure 45. Global Arthritic Therapeutic Revenue Share by Application in 2021
Figure 46. Global Arthritic Therapeutic Market Share Forecast by Application (2023-2028)
Figure 47. North America Arthritic Therapeutic Sales Market Share by Type (2017-2028)
Figure 48. North America Arthritic Therapeutic Sales Market Share by Application (2017-2028)
Figure 49. North America Arthritic Therapeutic Revenue Market Share by Country (2017-2028)
Figure 50. United States Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Arthritic Therapeutic Sales Market Share by Type (2017-2028)
Figure 54. Europe Arthritic Therapeutic Sales Market Share by Application (2017-2028)
Figure 55. Europe Arthritic Therapeutic Revenue Market Share by Country (2017-2028)
Figure 56. Germany Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Arthritic Therapeutic Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Arthritic Therapeutic Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Arthritic Therapeutic Revenue Market Share by Region (2017-2028)
Figure 64. China Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Arthritic Therapeutic Sales Market Share by Type (2017-2028)
Figure 71. South America Arthritic Therapeutic Sales Market Share by Application (2017-2028)
Figure 72. South America Arthritic Therapeutic Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Arthritic Therapeutic Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Arthritic Therapeutic Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Arthritic Therapeutic Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Arthritic Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
